This trial studies how a game-based exercise plan works in increasing the level of physical activity in childhood cancer survivors and their parent/guardian. Physical activity is important for leading a healthy lifestyle, but in childhood cancer survivors, it’s especially important because cancer treatments can have long-term side effects that affect the heart, blood vessels, and blood sugar levels. Physical activity can prevent these side effects and improve quality of life.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04266080.
PRIMARY OBJECTIVES:
I. Assess the feasibility and acceptability of using a parent-child based social incentive-intervention to increase physical activity in childhood cancer survivors at risk for cardiometabolic disease who are otherwise sedentary.
II. Evaluate the preliminary effects of a parent-child based social incentive-intervention to increase physical activity in childhood cancer survivors at risk for cardiometabolic disease who are otherwise sedentary.
IIa. Assess the proportion of child participant-days that step goals were achieved during the 3-month intervention period on all days of the intervention (weeks 2-13).
IIb. Assess the proportion of child participant-days that step goals were achieved during the 3-month follow-up period on all days of the follow-up period (weeks 14-26).
IIc. Explore proportions of parents versus children who meet their step goals during the intervention.
III. Estimate differences in health-related quality of life (HRQoL) (using self-report and parent-report surveys) before and after a 3-month physical activity intervention in the parent-child dyads described above.
EXPLORATORY OBJECTIVES:
I. Explore the association between mean daily step count and calculated moderate to vigorous physical activity (MVPA) per day per participant.
II. Explore the association between mean daily step count and hours of sleep per night.
OUTLINE:
Patients and their parent/caregiver wear a FitBit Inspire HR for 3 months to track steps taken and meet a step goal.
After completion of study, patients are followed up for 3 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationMemorial Sloan Kettering Cancer Center
Principal InvestigatorDanielle Novetsky Friedman
